Analysis of risk factors for post-operative complications and prognostic predictors of disease recurrence following definitive treatment of patients with esophageal cancer from two medical centers in Northwest China
Jichang Wang(First Affiliated Hospital of Xi'an Jiaotong University), Xin Sun(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 12
Related Papers
Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
|Journal of Experimental & Clinical Cancer Research|2019|141
Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
|Oncotarget|2015|107
M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way
|Journal of Experimental & Clinical Cancer Research|2021|92